SmartLedger's Physics Engine for Pharma, Materials & Verified AI.
SmartLedger Technology has built a physics-driven discovery and optimization engine capable of extreme candidate-space exploration on workstation-class GPU hardware.
The platform has demonstrated 500 million spins in 21 seconds on a single high-end GPU environment, creating a new economic model for discovery: generate, rank, prove, validate, and license.
This is not a normal seed round.
SmartLedger is raising for a deep-tech platform with working throughput, a broad candidate universe, blockchain provenance, enterprise infrastructure, and commercialization paths across several massive markets.
spins
Completed in approximately 21 seconds on a single high-end GPU environment described as NVIDIA Blackwell-class / RTX workstation-class and Ada 6000-class testing.
Physics-Driven Search
Explore vast state spaces, rank candidates, and optimize hard problems using hardware-efficient computational physics rather than brute-force exploration.
Proof by Design
Outputs can be hashed, timestamped, signed, Merkle-batched, and anchored to blockchain proofs for independent verification and reproducibility.
Candidate Generation
Generate and rank molecular and materials candidates by target properties, scaffold diversity, novelty, feasibility, and expected validation value.
Commercial API Layer
ORIGIN Neural AI turns SmartLedger's engine into APIs, dashboards, proof explorers, marketplaces, and enterprise licensing workflows.
Market valuation is the reason to ask bigger.
The physics engine is not tied to one vertical. The same core capability can serve pharma discovery, materials science, industrial optimization, government, defense, energy, batteries, catalysts, semiconductors, and specialty chemicals.
Pharma Discovery
Pharma is a multi-trillion-dollar global market. The value path is not claiming every computational candidate is a drug. The path is targeted validation: candidate universe → ranked queue → wet-lab hits → lead series → licensing.
Materials Science
Materials can commercialize faster than therapeutics. Validate a measurable property, package the result with provenance, and license it into industrial R&D and manufacturing channels.
Optimization
Million-variable Ising, 3-SAT, routing, logistics, energy minimization, scheduling, portfolio optimization, and complex enterprise planning.
Government + Defense
Advanced materials, supply-chain resilience, secure AI provenance, post-quantum readiness, and audit-ready optimization workflows.
Verified Prediction Infrastructure
Proof-backed datasets, prediction records, model integrity proofs, Axiom Vault catalogue access, and enterprise reproducibility layers.
Proposed terms: capital without surrendering the engine.
SmartLedger should sell equity in the company or designated commercialization entity, not ownership of the physics engine itself. Strategic rights should be narrow, field-limited, and tied to funded validation programs.
Preferred Round Structure
| Term | Recommendation |
|---|---|
| Round Size | $25M strategic deep-tech round. |
| Equity Cap | 15% equity for the full round. |
| Implied Minimum Valuation | At $25M for 15% post-money, implied post-money is about $166.7M and implied pre-money is about $141.7M. A stronger target is $200M pre-money. |
| Target Valuation | $200M pre-money; $225M post-money; $25M investor ownership equals 11.11%. |
| First Close | $10M to immediately fund benchmarking, validation, patents, pilots, and business development. |
| Strategic Expansion | Option to expand to $50M only for strategic investors bringing major pharma, materials, defense, or government access. |
What Investors Receive
| Investor Type | Return Package |
|---|---|
| Financial Investor | Preferred equity or SAFE with valuation cap. No operational control of IP. |
| Strategic Pharma | Equity plus limited first-look rights on defined target families funded by the program. |
| Strategic Materials | Equity plus field-limited option on a defined class, such as battery electrolytes, catalysts, coatings, or polymers. |
| Government / Defense | Paid prototype, secure deployment, proof infrastructure, and advanced materials/optimization workflows. |
| Enterprise API Partner | Annual access, support, dashboards, proof explorer, and custom workflows. |
Revenue path: platform fees, campaigns, licensing, and JVs.
The engine creates multiple revenue paths instead of depending on a single moonshot drug or a single materials product.
Enterprise APIs
ORIGIN Neural AI sells access to optimization, candidate generation, proof explorer, and ranking workflows.
Paid Discovery Campaigns
Partners fund targeted pharma, battery, catalyst, polymer, coating, defense, or semiconductor discovery programs.
Candidate Licensing
Validated candidates become licensable assets with upfronts, milestones, royalties, and field-limited industrial rights.
Axiom Vault Marketplace
Gated access to candidate records, proof batches, prediction metadata, ranked libraries, target families, and exclusive licensing packages.
Strategic Joint Ventures
SmartLedger contributes engine, candidates, proof infrastructure, and AI/API layer. Partners contribute capital, labs, market access, manufacturing, and regulatory channels.
Use of funds and milestone plan.
The $25M round should turn the engine from extraordinary technical capability into validated commercial proof packages.
Use of Funds
| Category | Allocation |
|---|---|
| Pharma wet-lab validation | $5.0M |
| Materials bench testing | $4.0M |
| Physics engine scaling + benchmarking | $4.0M |
| API/product engineering | $3.0M |
| IP, patents, legal, licensing | $2.0M |
| Axiom Vault commercialization | $2.0M |
| Enterprise/government pilots | $2.0M |
| GPU/proof infrastructure | $1.5M |
| Business development | $1.5M |
Milestones Funded
| Timeline | Milestone |
|---|---|
| 0–90 days | Independent benchmark report on 500M spins / 21 seconds, hardware profile, reproducible test script, and comparison suite. |
| 0–120 days | Patent filings, IP memo, data room, proof records, and licensing templates. |
| 3–6 months | Top pharma and materials candidate queues organized by target, property, scaffold, novelty, and feasibility. |
| 6–9 months | First wet-lab and materials bench validation results. |
| 9–12 months | First paid discovery campaigns and enterprise API contracts. |
| 12–24 months | Candidate licensing packages, strategic JVs, Series A or strategic acquisition optionality. |
Validation ladder.
Investors are not funding a claim. They are funding the conversion of working deep-tech performance into independently validated commercial assets.
Benchmark
Reproduce 500M spins / 21 sec with logs, videos, hardware specs, and external review.
Segment
Organize 31M+ candidates by pharma target, material class, property, novelty, and feasibility.
Validate
Run wet-lab assays and materials bench tests against high-value candidate queues.
Package
Bundle validated hits with provenance, reproducibility, IP review, and commercialization notes.
License
Convert validated packages into paid campaigns, licenses, JVs, royalties, and enterprise deployments.
Opening position: $25M for 15%.
SmartLedger Technology is not offering the physics engine for sale. The round funds commercialization, validation, APIs, patents, proof infrastructure, and partner programs while SmartLedger retains ownership and control of the core IP.